Hjem › Myasthenia gravis › Californien
Myasthenia gravis kliniske forsøg i Californien
20 studier for Myasthenia gravis søger deltagere på steder i Californien.
Byer i Californien
- Orange6 studier
- San Francisco6 studier
- Los Angeles4 studier
- Mountain View4 studier
- Carlsbad3 studier
- Pasadena3 studier
Officiel studietekst (engelsk)
Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
- Neurology Center of North Orange County, Fullerton
- The Neurology Group, Pomona
RekruttererFase 3
Alder 18 til 74 · Alle køn · Opdateret 25. sep. 2026 · NCT07217587A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)
- Cinical Study Site, Pasadena
RekruttererFase 3
Alder 18 til 80 · Alle køn · Opdateret 25. sep. 2026 · NCT07647510ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
- Profound Research LLC - Carlsbad, Carlsbad
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT07294170ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
- Profound Research LLC - Carlsbad, Carlsbad
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT07284420A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
- Tri Valley Neurology Medical Associates Inc., Mission Hills
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 11. sep. 2026 · NCT07501702A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, La Jolla
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT06680037Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
- University of California Irvine Medical Center, Irvine
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 21. aug. 2026 · NCT06414954A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
- Hoag Memorial Hospital Presbyterian, Newport Beach
- Stanford Neuroscience Health Center, Palo Alto
RekruttererFase 1
Alder 18 til 75 · Alle køn · Opdateret 14. aug. 2026 · NCT07304154RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
- University of California Irvine, Orange
- UC Davis, Department of Neurology, Sacramento
- University of California, San Francisco, San Francisco
RekruttererFase 1/2
Alder 18 til 70 · Alle køn · Opdateret 13. aug. 2026 · NCT06359041Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)
- University of California-San Francisco, San Francisco
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 til 64 · Kvinder · Opdateret 11. aug. 2026 · NCT06940323Study of Aritinercept in Patients With Generalized Myasthenia Gravis
- Aurinia Investigational Site, Pasadena
RekruttererFase 1/2
Alder 18 til 85 · Alle køn · Opdateret 3. aug. 2026 · NCT07596901A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
- Lucile Packard Children's Hospital Stanford, Palo Alto
- UCSF Benioff Children's Hospital, San Francisco
RekruttererFase 2/3
Alder 2 til 17 · Alle køn · Opdateret 31. jul. 2026 · NCT05265273Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1010, Carlsbad
- Site Number - 1028, Irvine
- Site Number - 1023, Los Angeles
- og 2 flere
RekruttererFase 3
Alder 18 til 80 · Alle køn · Opdateret 30. jul. 2026 · NCT07039916KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
- Ronald Reagan UCLA Medical Center, Los Angeles
- University of California, Irvine, Orange
- Stanford University Medical Center, Palo Alto
RekruttererFase 2/3
Alder 18 til 75 · Alle køn · Opdateret 29. jul. 2026 · NCT06193889A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- Care Access Research, Pasadena
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 27. jul. 2026 · NCT04951622A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
- University of Southern California, Los Angeles
- University of California Irvine, Orange
- University of California San Francisco (UCSF), San Francisco
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 18. jun. 2026 · NCT06456580A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
- UCLA Medical Center, Los Angeles
- University of California, Irvine, Orange
- Stanford Hospital, Palo Alto
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 25. feb. 2026 · NCT06626919Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
- Clinical Trial Site, Fresno
- Clinical Trial Site, Orange
- Clinical Trial Site, Rancho Mirage
- og 1 flere
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 18. feb. 2026 · NCT04202341A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
- UCSF Medical Center - Helen Diller Family Comprehensive Cancer Center - Brain Tumor Center,, San Francisco
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 17. feb. 2026 · NCT06298565Vitaccess Real MG Registry
- UCI Health, Orange
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 29. jul. 2025 · NCT06064461Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.